HIV-1 infection between subject groups.) Second, differences in the specific enrollment criteria of the two studies meant that 305 HIV-negative women from the Lancet study did not meet initial enrollment criteria for the HIV-2 protection study and so were excluded. Third, women in the HIV-2 protection study that did not attend their scheduled visits were actively followed by a team of physicians and clinic workers. This active follow-up was not part of the protocol of the Lancet study (1) , in which we stated that loss to follow-up might have resulted in an underestimate of HIV-1 incidence among HIV-negative women.
Greenberg et al. prematurely conclude that our matching procedure (2) may have resulted in a selection bias that would be responsible for the protective effect of HIV-2. To address these concerns, we performed the HIV-2 protection analysis on a nonmatched study population that included 199 HIV-2-positive (12 added from 1994 through 1995) and 1264 HIV-negative women. Seven women became dually infected among the 199 HIV-2-seropositive women, and 83 women seroconverted to HIV-1 among the 1264 HIV-seronegative women. The adjusted incidence rate ratio (IRR) for HIV-2-positive women was 0.36 (95%CI = 0.13 to 0.99), which was statistically significant (P < 0.05) ( Table 1) . Because the Lancet study had clearly shown Ghanaian nationality as a predictor of HIV-1 seroconversion (adjusted RR 2.70; 95%CI = 1.28 to 5.72) (1), we performed a sensitivity analysis to evaluate its potential effect on HIV-2 protection. All HIV-negative and HIV-2-positive Ghanaians that were lost to follow-up were coded as HIV-1 seroconverters, the adjusted IRR for HIV-2-positive women was 0.48 (95%CI = 0.24 to 1.00), which was statistically significant (P < 0.05) ( Table 1 ). This analysis demonstrates the protective effect of HIV-2 even when we account for potential differential risk in those who were lost to follow-up.
As suggested, we analyzed 187 HIV-2-positive women; each one was compared with two randomly selected HIV-negative women (n = 374) matched on age, nationality, and years of registered prostitution. This is a lower number of HIV-negative women than reported (2) as a result of our removing: all negative women matched to HIV-1-positive women, all HIV-1 seroconverters that were not originally matched as seronegative women, and HIV-2 seroconverters who contributed seronegative person-time. Seven women became dually infected among the 187 HIV-2-seropositive women, and 41 women seroconverted to HIV-1 among the 374 HIV-seronegative women. We constructed a multivariate Poisson regression model as described in our report (2) , and the adjusted IRR for HIV-2-positives was 0.27 (95%CI = 0.10 to 0.76), which was statistically significant (P < 0.05) ( Table 1) . When we added new data from 1994 through 1995, the adjusted IRR for HIV-2-positive women was 0.26 (95%CI = 0.09 to 0.72), which was statistically significant (P < 0.05) ( Table 1 ).
In a recent report (1) (1). That most cell-free virus is derived from CD4 lymphocytes that die rapidly on active infection is suggested by the rapid dynamics of changes in concentrations of cell-free virus on administration of antiretroviral durgs (2, 3), together with the correlation between treatment-induced changes in plasma virus concentrations and CD4 lymphocyte counts (4-6). Nonetheless, the hypothesis that the decline in plasma virus concentration in primary HIV infection may be a result of depletion of susceptible cells is general and, given that cells producing most plasma virus are short-lived (2, 3), remains relevant if a proportion of these are assumed to be of monocyte-macrophage lineage.
Wilson et al. suggest that the fact that there is an association between CD8 cell activation early in HIV infection and a poor prognosis argues that these early activation events play a significant role in the resolution of the primary HIV syndrome. It is difficult to understand, however, why those patients with the greatest immunologic activity in this regard should experience the most rapid progression of HIV infection (7). On a further point, the finding of HIV-specific CTL responses in some HIV-exposed seronegative individuals (8), although of great interest, does not in itself indicate that they necessarily "play a central role in containing viral replication."
Findings from the mathematical models (9) have not disproved the concept of immune control of HIV during primary infection. They have merely pointed to an alternative explanation for the decline in virus which is no less consistent with existing data. The degree to which the decline can be attributed to any HIV-specific immune response, rather than to popu-In a recent study by Steven M. Wolinsky et al. (1), of which one of us, A.U.N., was a co-author, several biological parameters were found to be associated with the rate of disease progression in six individuals infected with human immunodeficiency virus (HIV). Rapid CD4 cell depletion and disease progression was associated with low anti-HIV cytolytic T lymphocyte (CTL) precursor frequency, high viral loads, and slow accumulation of genetically diverse viral forms. It was suggested (1, 2) that these measures could be explained by the effectiveness of the immune system in killing infected cells, and that a successful immune pressure resulted in adaptive evolution of HIV. An additional correlation with disease progression that was observed was a preponderance of unspliced cellular HIV messenger RNA (mRNA) as compared to spliced mRNA in rapid progressors. Current hypotheses suggest (3) that the observed differences in the ratio of unspliced to spliced RNA (U/S RNA ratio) among patients is accounted for by the patients having viruses with different viral properties.
The difference in the ratio of spliced to unspliced RNA might also be explained by differences in the effectiveness of the cellular immune response. HIV RNA production by an infected cell goes through several phases. In the early phase the viral transcript gets multiply spliced to express the early regulatory genes and there is no export of unspliced RNA from the nucleus. Only in the late phase of viral expression does unspliced RNA get exported to the cytoplasm (4). The U/S RNA ratio is therefore strongly dependent on the ratio of cells in the early phase, expressing only spliced RNA, versus the cells in the late phase, expressing also unspliced RNA. Faster killing of the cells in the early phase will not change the U/S RNA ratio, because the number of cells in the later phase depends on the number of cells that complete the early expression phase. Thus, if more early phase cells are killed, the amounts of both spliced and unspliced intracellular mRNA will be reduced proportionately. On the other hand, faster killing of the cells in the later expression phase will significantly reduce the amount of unspliced intracellular mRNA. Therefore, faster killing of infected cells in slow-progressors that have better CTL responses will give rise to a relatively low U/S RNA ratio. Slower killing of infected cells in rapid progressors will give, according to this hypothesis, higher U/S RNA ratio. This is consistent with higher U/S RNA ratios observed (1, 3, 5) in rapid progressors, which is associated (1) with weaker cellular immune responses.
This same hypothesis could explain the longitudinally observed (1, 3, 5) increase of the U/S RNA ratios as being related to weakening of the cellular immune response during the period of disease progression (2) . The hypothesis suggested here is in line with the one suggested by Wolinsky et al., that differences in the CTL response are the basis for differences in the rate of disease progression in these patients. A quantitative analysis of the hypothesis, using a mathematical model, gave the same results as described above (6 
